Back to Journals » Drug Design, Development and Therapy » Volume 9

Original Research

Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer

      
Total article views   HTML views PDF downloads Totals
10,239 Dovepress* 8,819+ 1,462 10,281
PubMed Central* 1,420 421 1,841
Totals 10,239 1,883 12,122
*Since 8 June 2015
+Since July 2016

View citations on PubMed Central and Google Scholar